Efficacy of Switching to Bilastine, a Histamine H1 Receptor Antagonist, in Patients With Chronic Spontaneous Urticaria (H1-Switch): Study Protocol for a Randomized Controlled Trial

Trials - United Kingdom
doi 10.1186/s13063-019-3878-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search